Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of aluminium phosphate oral suspension for epigastric pain caused by chronic gastritis
CTR20253554Phase 3Active
- Sponsor
- Pharmatis
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aluminum phosphate in chronic gastritis, sponsored by Pharmatis. Started Sep 2025; status: active.
02
Drugs
aluminum phosphate
03
Conditions
chronic gastritis
Beyond the preview
Go deeper on CTR20253554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253554.